Clinical trial
INI1 Mutation Analysis and Expression Profiling of Embryonal CNS Tumors
NCT00010101 is registered in ClinicalTrials.gov with Pediatric Brain Tumor Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INI1 Mutation Analysis and Expression Profiling of Embryonal CNS Tumors
- Lead sponsor
- Pediatric Brain Tumor Consortium
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 31, 2001
- Completion date
- August 31, 2004
- Enrollment
- 38 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
central nervous system tumor, pediatric